Armed Oncolytic Immunotherapy Summit

Memo

Explore the next generation of armed oncolytic immunotherapies in combination which have the greatest potential for clinical and commercial success.



The Armed Oncolytic Immunotherapy Summit is your opportunity to hear the most up-to-date clinical advances alongside novel therapeutic strategies to increase potency, targeting and immune cell recruitment, in the effort to turn cold tumours hot.



http://www.oncolytic-immunotherapies.com/

26-28 June, 2018



Contact:

This email address is being protected from spambots. You need JavaScript enabled to view it.

+44 (0)20 3141 8700



Category: Conferences | Science, Health and Medicine | Oncology



Prices:



Conference + 2 Workshops Earlybird (Book by 23/03/18): EUR 2197

Conference + 2 Workshops (standard rate): EUR 2597

Conference + 1 Workshop Earlybird (Book by 23/03/18): EUR 1798

Conference + 1 Workshop (standard rate): EUR 2198

Conference Earlybird (Book by 23/03/18): EUR 1399

Conference (Standard rate): EUR 1799

Workshop only: EUR 499



On Tuesday June 26, 2018 at 9:00 am (ends Thursday June 28, 2018 at 5:00 pm)



URLs:



Booking: https://go.evvnt.com/207531-0?pid=5569



Brochure: https://go.evvnt.com/207531-1?pid=5569



Speakers: Akseli Hemminki (TILT Biotherapeutics), Daniel Katzman (Unleash Immuno Oncolytics), Colin Love (Replimune), Gabriella Campadelli-Fiume (NousCom), Frank Tufaro (DNAtrix), Stephen Russell (Vyriad)



Venue details: Le Meridien Frankfurt, Wiesenhuettenplatz 28-38, Frankfurt, 60329, Germany